U.K approves Pfizer/BioNTech Covid-19 vaccine for children age between 12 and 15 years
United Kingdom has approved Pfizer/BioNTech Covid-19 vaccine for children aged between 12 and 15 years old, a Reuters report said.
According to the report, in March, Pfizer Inc and German partner BioNTech SE had begun testing their Covid-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the US drug maker had said.
The Pfizer/BioNTech vaccine was authorized by US regulators in late December for people age 16 and older, the report said.
In May, the US pharma giant Moderna had said its Covid-19 vaccine protects children as young as 12. In the same month, the US and Canada authorized Pfizer’s vaccine for use in children aged 12 and above, Reuters reported.